← Eichor
Study identifier: NCT04379115 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Optimization of NIBS for Treatment of Addiction

Condition: Opioid-use Disorder · Chronic Pain  ·  Sponsor: Case Western Reserve University

PhaseNA
Planned participants126
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

The purpose of this study is to assess the effects of transcranial Direct Current Stimulation (tDCS) applied in conjunction with Transcranial Ultrasound (TUS) for the treatment of addiction in opiate use disorder with chronic pain. The investigators hypothesize that there will be a decrease in drug use and improved psychosocial assessments with active stimulation, when compared to sham stimulation.

This description comes directly from the study's public registry record.

Talk to the study team

Kimberly Bass, RN  ·  216-286-7250  ·  kimberly.bass@uhhospitals.org

Mario Becerra, RN  ·  216-844-1734  ·  Mario.Becerra@UHHospitals.org

Always discuss trial participation with your own doctor first.

Locations (3)

University of Illinois Health/ University of Illinois at ChicagoHinsdale, Illinois, United StatesRecruiting
Spaulding Rehabilitation Hospital - 5th Floor - Neuromodulation CenterCambridge, Massachusetts, United StatesRecruiting
University Hospitals Cleveland Medical Center/ Dahms Clinical Research UnitCleveland, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04379115